OBJECTIVE: To evaluate the effects of clinical pharmacists participating in clinical pathway management for chronic heart failure (CHF). METHODS: A total of 107 CHF adult inpatients in Linyi People’s Hospital during Jan. 2014-Oct. 2015 were divided into control group (56 cases, 3 withdrawal, 53 in total) and trial group (58 cases, 4 withdrawal, 54 in total) according to random number table. Control group received routine clinical pathway management method of CHF; trial group received clinical pathway management with the participation of clinical pharmacists. Clinical efficacy, the utilization of heart failure drugs, economic indexes, medication compliance after discharge, re-hospitalization rate due to heart failure were compared between 2 groups. RESULTS: Total response rate of trial group was significantly higher than control group, with statistical significance (P<0.05). The utilization rate of ACEI/ARB, β-receptor blocker, target dose rate of ACEI/ARB in trial group were significantly higher than control group, with statistical significance (P<0.05); target dose rate of β-receptor blocker was higher than control group, without statistical significance (P>0.05). Hospitalization time, drug cost, total hospitalization cost and drug ratio of trial group were shorter or lower than control group, without statistical significance (P>0.05). One month after discharge, the proportion of medication compliance in trial group was significantly higher than control group, with statistical significance (P<0.05); re-hospitalization rate was lower than control group, without statistical significance (P>0.05). Three months after discharge, the proportion of medication compliance in trial group was higher than control group, while re-hospitalization rate was lower than control group, with statistical significance (P<0.05). CONCIUSIONS: The participation of clinical pharmacists in clinical pathway management of CHF can significantly improve the utilization rate of recommended drugs by guideline, clinical efficacy and medication compliance, and reduce re-hospitalization rate.
关键词
慢性心力衰竭临床路径临床药师药学服务
Keywords
Chronic heart failureClinical pathwayClinical pharmacistPharmaceutical care